Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hunlicar Group Limited Board/Management Information 2021

Jan 15, 2021

50852_rns_2021-01-15_3e3c53a8-6af4-4b26-b9ca-85bddef4091f.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [363 x 59] intentionally omitted <==

(Incorporated in the Cayman Islands with limited liability) (Stock code: 3638)

APPOINTMENT OF EXECUTIVE DIRECTOR

The board (the “ Board ”) of directors (the “ Directors ”) of Huabang Financial Holdings Limited (the “ Company ” together with its subsidiaries, the “ Group ”) announces that Ms. Shen Wei (“ Ms. Shen ”) has been appointed as an executive Director (the “ Appointment ”) of the Company with effect from 15 January 2021.

Ms. Shen, aged 56, is a founder of Group and is the spouse of Mr. George Lu who is the Executive Director, Chief Executive Officer and Chairman of the Company. Ms. Shen had been a Director of the Company since January 2011 and was re-designated as an Executive Director from June 2012 to January 2017. Ms. Shen is responsible for the overall management and strategic development of the Group. Ms. Shen is also a director and legal representative of Boda Technology (Shenzhen) Company Limited, a wholly owned subsidiary of the Company. Ms. Shen has extensive experience in the computer and peripheral products industry. Ms. Shen studied Pharmacology at the China Pharmaceutical University and graduated with a Bachelor of Science degree in 1987. Ms. Shen also obtained a Master of Science degree in Toxicology from the University of New Mexico in 1991 and worked as a postgraduate researcher in the School of Pharmacy, Department of Pharmacy of the University of California, San Francisco from 1991 to 1994. Ms. Shen had been a non-executive director of Qianhai Health Holdings Limited (Stock Code: 911), a company listed on the Main Board of the Stock Exchange from May 2016 to January 2017.

Save as disclosed above, Ms. Shen did not hold any directorship in the last three years in any public companies the securities of which are listed on any securities market in Hong Kong or overseas. As at the date of this announcement, Ms. Shen does not have any relationship with any Directors, senior management, substantial shareholders or controlling shareholders (as defined in the Rules Governing the Listing of Securities on the Stock Exchange (the “ Listing Rules ”)) of the Company save as disclosed above. Further, as at the date of this announcement, Ms. Shen is deemed to be interested in 2,414,552,000 shares of the Company (the “ Shares ”) through interest in controlled corporation, Forever Star Capital Limited, a controlling shareholder of the Company which is owned as to 50% by Ms. Shen and 50% by Mr. George Lu. Ms. Shen is also deemed to be interested in 145,800,000 Shares through interest of spouse, Mr. George Lu, the beneficial owner of these Shares. Save as

  • 1 -

disclosed herein and as at the date of this announcement, Ms. Shen does not have any interests in the Shares within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

Pursuant to a service agreement signed by the Company and Ms. Shen, Ms. Shen’s term of services with the Company is not appointed for a specific term and can be terminated by giving three months’ prior written notice or in certain circumstances as in accordance with the terms of the service agreement. Ms. Shen will hold office until the next following annual general meeting of the Company after her appointment and will then be eligible for re-election in accordance with the Company’s memorandum and articles of association and the Listing Rules. Pursuant to the service agreement, Ms. Shen does not receive remuneration from the Company on the appointment and her remuneration is subject to the recommendation by the remuneration committee of the Company and review by the Board from time to time with reference to the prevailing market conditions and Ms. Shen’s effort and expertise.

Save as disclosed above, the Board is not aware of any matters relating to the Appointment of Ms. Shen that needs to be brought to the attention of the shareholders of the Company, and Ms. Shen confirmed that there is no other information that should be disclosed pursuant to Rule 13.51(2)(h) to (v) of the Listing Rules.

The Board would like to extend its warm welcome to Ms. Shen in her new position in the Board.

By Order of the Board Huabang Financial Holdings Limited George Lu Chairman & Chief Executive Officer

Hong Kong, 15 January 2021

As at the date of this announcement, the executive Directors of the Company are Mr. George Lu and Ms. Shen Wei; the non-executive Director of the Company is Mr. Pang Chung Fai Benny; and the independent non-executive Directors of the Company are Mr. Loo Hong Shing, Vincent, Mr. Zhu Shouzhong and Mr. Li Huaqiang.

  • 2 -